new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)

Filing Names

Eli Lilly And Company
Eli Lilly And Company An Indiana Corporation
Eli Lilly And Company_20131212
Eli Lilly And Company Patent Division

Eli Lilly And Company patents

Recent patent applications related to Eli Lilly And Company. Eli Lilly And Company is listed as an Agent/Assignee. Note: Eli Lilly And Company may have other listings under different names/spellings. We're not affiliated with Eli Lilly And Company, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "E" | Eli Lilly And Company-related inventors

Date Eli Lilly And Company patents (updated weekly) - BOOKMARK this page
04/27/17 new patent  Glucagon receptor agonists
04/27/17 new patent  Glucagon receptor agonists
04/20/17Antibodies to tau and uses thereof
04/06/17Transdermal formulations of pergolide and uses thereof
04/06/17Rotatable end of dose feedback mechanism
03/16/17Cgrp antibodies
03/09/17Inhibitors of ezh2
03/09/17Compounds useful for inhibiting ror-gamma-t
03/02/17Rapid-acting insulin compositions
03/02/17Pd-l1 antibodies
02/16/17Pyridinoylpiperidines as 5-ht1f agonists
02/16/17Cgrp receptor antagonists
02/16/17Cgrp receptor antagonists
02/09/17Jak1 inhibitors
02/02/17Phenyl-triazolo-pyridine compounds
12/29/16Erk inhibitors
12/22/16Rapid-acting insulin compositions
12/22/162-oxo-1,3,8-triazaspiro[4.5]decan-3-yl] carboxylic acid derivatives
12/22/16Glucagon and glp-1 co-agonist compounds
12/22/16Anti-met in combination with anti-vegfr2 antibodies therapy for cancer
12/01/16Injection needle covering system
11/17/16Isopropyl triazolo pyridine compounds
11/10/16Fusion proteins
11/10/165'-substituted nucleoside compounds
11/03/16Selective bace1 inhibitors
10/27/16Novel compound for treatment of severe hypoglycemia
10/27/16Novel compound for treatment of severe hypoglycemia
10/27/16Novel compound for treatment of severe hypoglycemia
10/06/16Fluorophenyl pyrazol compounds
10/06/16Anti-cd20- / anti-baff bispecific antibodies
09/29/16Il-17 antibody formulation
09/22/16Phenoxyethyl cyclic amine derivatives and their activity as ep4 receptor modulators
09/01/16Dimethylbenzoic acid compounds
09/01/16Pyrido[2,3-d]pyrimidin-4-one compounds as tankyrase inhibitors
09/01/16Antibodies to tau and uses thereof
09/01/16Anti-baff-anti-il-17 bispecific antibodies
08/25/16Selective bace1 inhibitors
08/18/16Methods and compositions for reducing the environmental impact of animal waste
08/11/16Compounds and their use for preparation of tau imaging agents and tau imaging formulations
08/11/16Novel pyridyloxyacetyl tetrahydroisoquinoline compounds useful as nampt inhibitors
07/28/16Process and device for delivery of fluid by chemical reaction
07/28/16Process and device for delivery of fluid by chemical reaction
07/28/164--5-(propan-2-yl)-1h-pyrazol-3-yl beta-d glucopyranoside acetate
07/28/16Vegfa/ang2 compounds
07/14/16Gip and glp-1 co-agonist compounds
06/23/16Erk inhibitors
06/16/16Rapid-acting insulin compositions
06/09/16Inhibitors of ezh2
06/02/16Pan-elr+ cxc chemokine antibodies
05/19/16Aurora a kinase inhibitor
05/12/16Rapid-acting insulin compositions
05/05/16Azetidinyloxyphenylpyrrolidine compounds
05/05/16Anti-tnf- / anti-il-23 bispecific antibodies
04/28/16Parasiticidal compounds, methods, and formulations
04/14/16Single dose oral formulations and methods for treatment of cats with ectoparasiticidal spinosad
04/07/16Aminopyridyloxypyrazole compounds
03/24/16Medication injector apparatus with drive assembly that facilitates reset
03/03/16Novel intermediate and process useful in the preparation of -(2-chlorophenyl)-methanone
02/25/16Phenoxyethyl dihydro-1h-isoquinoline compounds
02/11/16Methods for producing fabs and bi-specific antibodies
01/28/16Modified animal erythropoietin polypeptides and their uses
01/14/16Trigger assembly for an automatic injection device
01/07/16Delay mechanism suitable for compact automatic injection device
12/31/15Pyridinoylpiperidines as 5-ht1f agonists
12/24/15Dispenser for a medication
Patent Packs
12/24/15Dihydropyrido pyrimidine compounds as autotaxin inhibitors
12/24/15Imidazo pyridine compounds
12/10/15(thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists
12/10/151-hydroxy-benzooxaboroles as antiparasitic agents
12/03/156-substituted-3h-1,3-benzothiazol-2-one compounds as tarp-gamma 8 dependent ampa receptor antagonists
11/19/15Vegfr2/ang2 compounds
11/19/15Ang2 antibodies
11/12/15(thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as selective 5-ht2a inverse agonists
11/05/15Chemical engines and methods for their use, especially in the injection of highly viscous fluids
10/22/15Pegylated insulin lispro compounds
10/08/15Novel benzyl sulfonamide compounds useful as mogat-2 inhibitors
09/24/15Il-21 antibodies
09/17/15Cgrp antibodies
09/03/15Automatic injection device with trigger assembly
08/20/15Bace inhibitors
Patent Packs
08/20/15Antibodies that bind il-23
07/30/15Bace inhibitors
07/23/15Methods for improving chicken production
07/02/15Multi-specific igg-(fab)2 constructs containing t-cell receptor constant domains
06/25/15Multifunctional antibodies binding to egfr and met
06/18/15Noveltriazolo-pyridine compound
06/11/15Tetrahydropyrrolothiazine compounds
06/04/15Transdermal dispensing apparatus and methods
06/04/15Methods to restore glycemic control
05/28/15Novel dgat2 inhibitors
05/28/15Pyridone amides and analogs exhibiting anti-cancer and anti-proliferative activities
05/21/15Fibroblast growth factor 21 variants
05/21/15Therapeutic uses of fibroblast growth factor 21 proteins
05/14/15Azetidinyloxyphenylpyrrolidine compounds
05/14/15Ghrelin o-acyl transferase inhibitor
05/14/15Inhibitor of jak1 and jak2
05/14/15Atomoxetine solution
05/07/15Novel urea compounds
05/07/15Phenoxyethyl piperidine compounds
04/30/15Anti-c-met antibodies
04/30/15Raf inhibitor compounds
04/23/15Treatment for comorbid diabetes with chronic kidney disease
04/23/15Novel urea compounds
04/16/15Raf inhibitor compounds
03/12/15Parasiticidal dihydroisoxazole compounds
02/12/15Ectoparasiticidal methods and formulations
02/12/15Plunger for a medication cartridge
02/05/15Gearing mechanism for a dose delivery device
01/29/15Imaging agents for detecting neurological dysfunction
01/08/15Il-17 antibody formulation
Social Network Patent Pack
01/01/15Novel morpholinyl derivatives useful as mogat-2 inhibitors
12/18/14Methods and compositions for reducing the environmental impact of animal waste
12/18/14Bace inhibitors
12/18/14Phenyl methanesulfonamide derivatives useful as mgat-2 inhibitors
12/04/143,4-dihydroisoquinolin-2(1h)-yl compounds
11/27/14Anti-c-met antibodies
10/30/14Medicinal patch and injector system
10/16/14Spirothienopyran-piperidine derivatives as orl-1 receptor antagonists for their use in the treatment of alcohol dependence and abuse
10/02/14Injection devices with ergonomic enhancements
09/18/14Pan-elr+ cxc chemokine antibodies
Patent Packs
09/18/14Random homozygous gene perturbation (rhgp) with thermal assymetric interlaced (tail)-pcr
09/18/14Therapeutic uses for vegfr1 antibodies
09/18/14Azetidinyloxyphenylpyrrolidine compounds
09/18/14Tetrahydropyrrolothiazine compounds
09/18/14Cdc7 inhibitors
09/11/14Anti-tnf-anti-il-17 bispecific antibodies
09/11/14Antibodies that bind to il-23
09/11/14Tetrahydropyrrolothiazine compounds
08/21/14Hematopoietic neoplasm chemotherapy
08/21/14Phenoxyethoxy compounds
08/21/14Automatic injection device with delay mechanism including dual functioning biasing member
08/14/14Fibroblast growth factor 21 proteins
07/24/14Methods to restore glycemic control
07/24/14Novel intermediate and process useful in the preparation of -(2-chlorophenyl)-methanone
07/17/14Bicyclic pyrimidine compounds
06/26/14Refill module for an injection device
06/26/14Locking assembly for preventing dispensing of dose from medication dispensing device
06/19/14Bmp-6 antibodies
06/19/14Animal supplements and compositions containing soluable monensin and methods therefor
06/12/14Novel pyrazole compounds
06/12/14Animal supplements and food compositions containing soluble monensin composition, and methods and processes therefor
05/29/146-((s)-1--ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist
05/22/14Medication injector apparatus with drive assembly that facilitates reset
05/15/14Ectoparasiticidal methods and formulations
05/01/14(thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity h1 inverse agonists/5-ht2a antagonists
04/24/14Bicyclo (3.1.0) hexane-2, 6-dicarboxylic acid derivatives as mglu2 receptor agonist
04/17/14Parasiticidal dihydroisoxazole compounds
04/10/14Novel urea compounds
04/03/14Tetrahydropyrrolothiazine compounds
04/03/14Dimethyl-benzoic acid compounds
Patent Packs
03/06/14Anti-n3pglu amyloid beta peptide antibodies and uses thereof
02/27/14Homodimeric proteins
01/23/14Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity
12/12/13Fibroblast growth factor 21 proteins
12/05/13Fibroblast growth factor 21 variants
12/05/13Variants of human gdnf
11/14/13Novel pyrazole compounds
10/24/13Anti-baff-anti-il-17 bispecific antibodies
10/24/13Bovine viral diarrhea virus type 1b vaccine compositions and methods
10/10/13Compositions and methods for identifying and differentiating viral components of multivalent shipping fever vaccines
10/03/13Tetrahydropyrrolothiazine compounds
09/26/13Raf inhibitor compounds
09/12/13Pi3 kinase/mtor dual inhibitor
09/12/134-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
08/29/133-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds
08/29/13Analgesic compounds, methods, and formulations
08/22/13Parasiticidal dihydroisoxazole compounds
08/22/13Selective androgen receptor modulators
08/15/13Methods for inhibiting insect infestations
08/01/13Novel benzyl sulfonamide derivatives useful as mogat-2 inhibitors
Social Network Patent Pack
07/25/13Compounds useful for inhibiting chk1
07/18/13Gearing mechanism for a dose delivery device
06/27/13Anti-hepcidin antibodies and uses thereof
06/06/13Anti-n3pglu amyloid beta peptide antibodies and uses thereof
05/23/13Boron-containing small molecules
05/23/13Boron-containing small molecules
05/16/13Anti-ferroportin 1 monoclonal antibodies and uses thereof
04/04/13Fibroblast growth factor 21 variants
03/21/13Antibodies to pcsk9 and uses thereof
03/21/13Process for solubilizing glucagon-like peptide 1 compounds
02/21/13Novel 1,2,3,4-tetrahydroquinoline derivative useful for the treatment of diabetes
02/14/13Potentiation of cancer chemotherapy by 7-(2, 5- dihydro- 4-imidazo [1, 2-a] pyridine-3-yl-2,5-dioxo-ih-pyrrol-3-yl)-9-fluoro-1,2,3,4 tetrahydro -2-(1-piperidinyl-carbonyl)-pyrrolo [3,2,1-jk] [1,4] benzodiazepine
01/31/13Notch pathway signaling inhibitor compound
01/24/13Methods to restore glycemic control
12/27/12Purine compounds used as cb2 agonists
12/27/12Pyridinoylpiperidines as 5-ht1f agonists
12/20/12Methods for controlling pain in equines using a transdermal solution of fentanyl
12/20/12Aldosterone synthase inhibitor
12/20/12Bace inhibitors
12/20/12Automatic injection device with delay mechanism including dual functioning biasing member
Social Network Patent Pack
12/13/12Disubstituted phthalazine hedgehog pathway antagonists
11/29/12Novel mch receptor antagonists
11/29/12Novel imidazole derivatives useful for the treatment of arthritis
10/18/12C-met antibodies
10/18/12Use of an fgf-21 compound and a glp-1 compound for the treatment of obesity
10/11/12Antibodies that bind tgf-alpha and epiregulin
10/04/12Methods for internally controlling or treating equine bot larvae
10/04/12Tetrahydrotriazolopyridine compounds as selective mglu5 receptor potentiators useful for the treatment of schizophrenia
09/13/12Therapeutic uses of soluble alpha-klotho
08/30/12Novel spiropiperidine compounds
08/23/12Spiropiperidine compounds as orl-1 receptor antagonists
08/16/12Methods for controlling pain in canines using a transdermal solution of fentanyl
08/16/12Process for solubilizing glucagon-like peptide 1 compounds
08/09/12Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists
08/02/12Method to treat using antagonistic anti-htnfsf13b human antibodies
07/19/12Pi3 kinase/mtor dual inhibitor
07/05/12Methods of treatment using a prodrug of an excitatory amino acid
06/21/12Novel imidazole-2-benzamide compounds useful for the treatment of osteoarthritis
06/14/12Akt inhibitors
06/07/12Oxazolo[5-4-b]pyridin-5-yl compounds
05/24/124-substituted-3-phenylsulfanylmethyl-bicyclo[3.1.0]hexane compounds as mglur 2/3 antagonists
05/24/12Needle cartridge for medication injection device
05/03/12Method for predicting weight gain associated with a pharmaceutical therapy
04/19/12Cathepsin s inhibitor compounds
04/05/12Formulations for bovine granulocyte colony stimulating factor and variants thereof
04/05/12Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol
03/22/12P70 s6 kinase inhibitors
03/08/12Trans-4-[[(5s)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl] (2-methyl-2h-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1h-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid
02/16/12Lauric acid distillate for animal feed
02/02/126 substituted 2, 3,4,5 tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonist
Social Network Patent Pack
02/02/12Compound useful as a c-met inhibitor
01/26/12Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel
01/26/12Apparatus for injecting a pharmaceutical with automatic syringe retraction following injection
12/22/11Mineralocorticoid receptor antagonist and methods of use
12/15/11Cgrp antibodies
12/01/11Purine derivatives as kinase inhibitors
11/24/11Enzastaurin for the treatment of cancer
11/17/11Selective estrogen receptor modulators for the treatment of vasomotor symptoms
11/03/116-arylalkylamino-2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
10/27/11Tetrasubstituted pyridazine hedgehog pathway antagonists
10/13/11Anti-sclerostin antibodies
09/29/11Novel peptides and methods for their preparation and use
09/01/11Glucagon receptor antagonists
09/01/11P70 s6 kinase inhibitor and mtor inhibitor combination therapy
08/25/11Compositions and methods of use for soluble thrombomodulin variants
08/25/11Methods of treatment using a prodrug of an excitatory amino acid
08/25/11Purine derivatives as kinase inhibitors
08/25/11P70 s6 kinase inhibitor and egfr inhibitor combination therapy
08/04/11Anti-hepcidin-25 selective antibodies and uses thereof
08/04/11Disubstituted phthalazine hedgehog pathway antagonists
07/21/11Tetrasubstituted pyridazines hedgehog pathway antagonists
07/07/11Selective estrogen receptor modulator for the treatment of osteoarthritis
07/07/11Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes
06/23/11Sars vaccine compositions and methods of making and using them
06/23/11Oxyntomodulin peptide analogue
06/23/11Oxyntomodulin peptide analogue
06/23/11Mglu2 agonists
06/16/11Inhibitors of diacylglycerol acyltransferase
05/26/11Glucagon receptor antagonists, preparation and therapeutic uses

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Eli Lilly And Company in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Eli Lilly And Company with additional patents listed. Browse our Agent directory for other possible listings. Page by